Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Strengthens Portfolio With Dalbavancin Powder

June 18 (Reuters) - Newbury Pharmaceuticals AB  NEWBRY.ST :
    * STRENGTHENS PORTFOLIO WITH DALBAVANCIN POWDER
    * REGULATORY FILLING TO TAKE PLACE IN NEAR FUTURE
    * LAUNCH IS PLANNED IN SWEDEN

Source text for Eikon:  ID:nMFN9qvZD6 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Newbury Pharmaceuticals AB

See all news